Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12-17 year-old adolescents
SCB-2019(一种佐剂重组SARS-CoV-2三聚体S蛋白亚单位COVID-19疫苗)在健康12-17岁青少年中的安全性和免疫原性
期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2023.2206359
Lopez, Pio; Bravo, Lulu; Buntinx, Erik; Borja-Tabora, Charissa; Velasquez, Hector; Rodriquez, Edith Johana; Rodriguez, Camilo A; Carlos, Josefina; Montellano, May Emmeline B; Alberto, Edison R; Salvani-Bautista, Milagros; Huang, Yung; Hu, Branda; Li, Ping; Han, Htay Htay; Baccarini, Carmen; Smolenov, Igor